ADC Therapeutics SA Annual Weighted Average Number of Shares Outstanding, Diluted from 2022 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ADC Therapeutics SA quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2022 to 2023.
  • ADC Therapeutics SA Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 95.7M shares, a 17.5% increase year-over-year.
  • ADC Therapeutics SA annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 81.7M shares, a 4.55% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 81.7M +3.56M +4.55% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 78.2M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.